Determine the necessary mass, volume, or concentration for preparing a solution.
Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at 2-8°C,Protected from light,Argon charged,Desiccated Ships Wet ice Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Bleomycin hydrochloride is a DNA synthesis inhibitor. Bleomycin hydrochloride is a DNA damaging agent. Bleomycin hydrochloride is an antitumor antibiotic.
| Canonical Smiles | CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.Cl |
|---|---|
| IUPAC Name | 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;hydrochloride |
| InChIKey | BODDZCXQPQPRES-OYALTWQYSA-O |
| INCHI | 1S/C55H83N17O21S3.ClH/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6;/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88);1H/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-;/m0./s1 |
| Isomeric SMILES | CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.Cl |
| Alternate CAS | 67763-87-5 |
| Molecular Weight | 1451.01(Average) |
| Reaxy-Rn | 60692813 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=60692813&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Peptidomimetics |
| Subclass | Hybrid peptides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Hybrid glycopeptides |
| Alternative Parents | Histidine and derivatives Fatty acyl glycosides of mono- and disaccharides N-acyl-alpha amino acids and derivatives Gamma amino acids and derivatives Alpha amino acid amides Disaccharides Beta amino acids and derivatives O-glycosyl compounds Pyrimidinecarboxylic acids and derivatives 2-heteroaryl carboxamides Thiazolecarboxamides 2,4-disubstituted thiazoles Aminopyrimidines and derivatives Aralkylamines Oxanes Imidolactams N-acyl amines Heteroaromatic compounds Imidazoles Carbamate esters Secondary alcohols Secondary carboxylic acid amides Organic carbonic acids and derivatives Primary carboxylic acid amides Dialkylamines Acetals Azacyclic compounds Oxacyclic compounds Primary alcohols Carbonyl compounds Hydrocarbon derivatives Hydrochlorides Monoalkylamines Organic oxides Organopnictogen compounds Organosulfur compounds Organic cations |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | Hybrid glycopeptide - Histidine or derivatives - Fatty acyl glycoside - Fatty acyl glycoside of mono- or disaccharide - N-acyl-alpha amino acid or derivatives - Gamma amino acid or derivatives - Alpha-amino acid amide - Glycosyl compound - Disaccharide - O-glycosyl compound - Beta amino acid or derivatives - N-substituted-alpha-amino acid - Alpha-amino acid or derivatives - Pyrimidine-6-carboxylic acid or derivatives - Thiazolecarboxamide - 2-heteroaryl carboxamide - Thiazolecarboxylic acid or derivatives - 2,4-disubstituted 1,3-thiazole - Aralkylamine - Aminopyrimidine - Imidolactam - Pyrimidine - Fatty acyl - N-acyl-amine - Fatty amide - Oxane - Imidazole - Heteroaromatic compound - Azole - Carbamic acid ester - Thiazole - Amino acid or derivatives - Secondary carboxylic acid amide - Secondary alcohol - Primary carboxylic acid amide - Carboxamide group - Carbonic acid derivative - Secondary amine - Azacycle - Acetal - Organoheterocyclic compound - Carboxylic acid derivative - Oxacycle - Secondary aliphatic amine - Organic nitrogen compound - Organic oxygen compound - Primary aliphatic amine - Organonitrogen compound - Organooxygen compound - Organosulfur compound - Carbonyl group - Primary alcohol - Primary amine - Hydrochloride - Amine - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Alcohol - Organic cation - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as hybrid glycopeptides. These are compounds containing a carbohydrate component linked to a hybrid peptide component. |
| External Descriptors | Not available |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Mar 10, 2026 | B649732 | |
| Certificate of Analysis | Mar 10, 2026 | B649732 | |
| Certificate of Analysis | Mar 10, 2026 | B649732 | |
| Certificate of Analysis | Mar 10, 2026 | B649732 | |
| Certificate of Analysis | Mar 10, 2026 | B649732 | |
| Certificate of Analysis | Jan 16, 2026 | B649732 | |
| Certificate of Analysis | Jan 16, 2026 | B649732 | |
| Certificate of Analysis | Jan 16, 2026 | B649732 | |
| Certificate of Analysis | Jan 16, 2026 | B649732 | |
| Certificate of Analysis | Nov 04, 2025 | B649732 | |
| Certificate of Analysis | Nov 04, 2025 | B649732 | |
| Certificate of Analysis | Nov 04, 2025 | B649732 | |
| Certificate of Analysis | Nov 04, 2025 | B649732 | |
| Certificate of Analysis | Sep 05, 2025 | B649732 | |
| Certificate of Analysis | Sep 05, 2025 | B649732 | |
| Certificate of Analysis | Sep 05, 2025 | B649732 | |
| Certificate of Analysis | Sep 05, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Jun 09, 2025 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 | |
| Certificate of Analysis | Dec 31, 2024 | B649732 |
| Solubility | H2O : 100 mg/mL (Need ultrasonic) DMSO : 50 mg/mL (ultrasonic and warming and heat to 60°C) |
|---|---|
| Sensitivity | Light and moisture sensitive |
| 1. Chunyan Li, Xiao Sun, Ang Li, Min Mo, Zhongxi Zhao. (2019) S-Allylmercaptocysteine attenuates Bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-β1/Smad and oxidative stress pathways. INTERNATIONAL IMMUNOPHARMACOLOGY, [PMID:31874367] [10.1016/j.intimp.2019.106110] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →